1. Wider, C, Vilariño-Güell, C, Heckman, M G, Farrer, M J, Ross, O A. 2010. SNCA, MAPT, and GSK3B in Parkinson disease: a gene-gene interaction study. In European journal of neurology, 18, 876-81. doi:10.1111/j.1468-1331.2010.03297.x. https://pubmed.ncbi.nlm.nih.gov/21159074/
2. Zhu, Ming-Chuang, Zhang, Yan-Hong, Xiong, Peng, Li, Guo-Liang, Zhu, Min. 2022. Circ-GSK3B up-regulates GSK3B to suppress the progression of lung adenocarcinoma. In Cancer gene therapy, 29, 1761-1772. doi:10.1038/s41417-022-00489-8. https://pubmed.ncbi.nlm.nih.gov/35821283/
3. Hamanaka, Kohei, Miyake, Noriko, Mizuguchi, Takeshi, Takata, Atsushi, Matsumoto, Naomichi. 2022. Large-scale discovery of novel neurodevelopmental disorder-related genes through a unified analysis of single-nucleotide and copy number variants. In Genome medicine, 14, 40. doi:10.1186/s13073-022-01042-w. https://pubmed.ncbi.nlm.nih.gov/35468861/
4. Chen, Jianhua, Wang, Meng, Waheed Khan, Raja Amjad, Shi, Yongyong, Ji, Weidong. 2015. The GSK3B gene confers risk for both major depressive disorder and schizophrenia in the Han Chinese population. In Journal of affective disorders, 185, 149-55. doi:10.1016/j.jad.2015.06.040. https://pubmed.ncbi.nlm.nih.gov/26186530/
5. Wang, Ruoyu, Tang, Dan, Ou, Longyun, Wu, Yu-Nan, Tian, Xuefei. 2024. β-Sitosterol alleviates the malignant phenotype of hepatocellular carcinoma cells via inhibiting GSK3B expression. In Human cell, 37, 1156-1169. doi:10.1007/s13577-024-01081-y. https://pubmed.ncbi.nlm.nih.gov/38814517/
6. Hemerich, Daiane, Svenstrup, Victor, Obrero, Virginia Diez, Hirschhorn, Joel N, Loos, Ruth J F. 2024. An integrative framework to prioritize genes in more than 500 loci associated with body mass index. In American journal of human genetics, 111, 1035-1046. doi:10.1016/j.ajhg.2024.04.016. https://pubmed.ncbi.nlm.nih.gov/38754426/
智鼠故事 
